The reduction in heart rate during exercise was associated with a significant increase in time to 1-mm ST-segment depression during ETT in a dose-dependent manner, and there was a statistical trend to improvement in time to limiting angina after just 2 weeks.
← all excerpts
Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
1
—
—